Effect of European Medicines Agency's regulatory measures on nimesulide utilization in Portugal

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):630-637. doi: 10.1002/pds.4424. Epub 2018 Mar 30.

Authors

Daniel Pinto¹, Ana Silva², Bruno Heleno¹, David Silvério Rodrigues¹, Isabel Santos¹, Pedro A Caetano³

Affiliations

¹ Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal.
² Regulatory Affairs Specialist Fellow, Portugal.
³ Former member Group for Independent Academic Information, Chronic Diseases Research Center, NOVA Medical School, Lisbon, Portugal.

PMID: 29602246
DOI: 10.1002/pds.4424

No abstract available

Keywords: drug regulation; nimesulide; pharmacoepidemiology; physicians practice patterns.

MeSH terms

Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Chemical and Drug Induced Liver Injury / epidemiology
Chemical and Drug Induced Liver Injury / etiology
Chemical and Drug Induced Liver Injury / prevention & control*
Drug Prescriptions / standards
Drug Prescriptions / statistics & numerical data
Drug Utilization Review / statistics & numerical data*
European Union
Humans
Incidence
National Health Programs / standards*
Portugal / epidemiology
Retrospective Studies
Sulfonamides / adverse effects*

Substances

Sulfonamides
nimesulide